6-methyl-2,3-pyridinedicarboxylic acid
Product Information
Molecular Formula
C8H7NO4
Molecular Weight
181.15
Description
6-methyl-2,3-pyridinedicarboxylic acid is a constituent of paramount significance in the biomedical. Widely harnessed in the formulation of pharmaceuticals aimed at a wide range of afflictions, encompassing cancer and neurodegenerative maladies, its intricate therapeutic modalities elevate it to an auspicious contender. Through the manipulation of particular biological phenomena, it holds immense promise as a therapeutic agent, poised to combat these ailments with precision.
Synonyms
6-METHYL PYRIDINE 2,3 DICARBOXYLIC ACID; 6-METHYL-2,3-PYRIDINEDICARBOXYLIC ACID; 6-METHYL-2,3-PYRIDINECARBOXYLICACID; 6-Methyl-2,3-pyridinedicarboxylic acid, HPLC 97%; 2,3-PYRIDINEDICARBOXYLIC ACID, 6-METHYL- (6CI,9CI); 6-METHYLQUINOLIC ACID
IUPAC Name
6-methylpyridine-2,3-dicarboxylic acid
SMILES
CC1=NC(=C(C=C1)C(=O)O)C(=O)O
InChI
InChI=1S/C8H7NO4/c1-4-2-3-5(7(10)11)6(9-4)8(12)13/h2-3H,1H3,(H,10,11)(H,12,13)
InChI Key
PHQBKLKZIXCRIX-UHFFFAOYSA-N
Boiling Point
414.8°C at 760mmHg
Melting Point
170°C (dec.)(lit.)
Flash Point
Not applicable
Purity
95%
Density
1.46g/cm3
Appearance
Crystalline powder
Safety Information
Hazards
H315 - H319 - H335
Precautionary Statement
P302 + P352 - P305 + P351 + P338
Computed Properties
XLogP3
0.6
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Rotatable Bond Count
2
Exact Mass
181.03750770 g/mol
Monoisotopic Mass
181.03750770 g/mol
Topological Polar Surface Area
87.5Ų
Heavy Atom Count
13
Formal Charge
0
Complexity
228
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-112409249-A | 6-methylpyridine-2, 3-dicarboxylic acid zinc complex and preparation method thereof | 2020-10-28 |
| CN-110818628-A | Preparation method of nitrogen-containing aromatic dicarboxylic acid | 2019-11-08 |
| CN-110818628-B | Preparation method of nitrogen-containing aromatic dicarboxylic acid | 2019-11-08 |
| US-2021115300-A1 | Composition and method for silicon oxide and carbon doped silicon oxide cmp | 2019-10-22 |
| WO-2021081162-A1 | Composition and method for silicon oxide and carbon doped silicon oxide cmp | 2019-10-22 |
| TW-202122523-A | Composition and method for silicon oxide and carbon doped silicon oxide cmp | 2019-10-22 |
| CN-109232405-A | 6- picoline -2,3- dicarboxylic acids nickel complex and preparation method thereof | 2018-09-13 |
| WO-2019104398-A1 | Cleansing compositions | 2017-11-29 |
| BR-112020010785-A2 | cleaning composition and method for cleaning hair | 2017-11-29 |
| AU-2018326734-A1 | Substituted 2-azabicyclo(3.1.1)heptane and 2-azabicyclo(3.2.1)octane derivatives as orexin receptor antagonists | 2017-09-01 |
Literatures
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 22495333 | 2012-05-28 | New monoacylhydrazidate-coordinated Mn2+ and Pb2+ compounds | Dalton transactions (Cambridge, England : 2003) |
| 21189019 | 2011-01-27 | Identifying chelators for metalloprotein inhibitors using a fragment-based approach | Journal of medicinal chemistry |
| 20533466 | 2010-07-19 | The equilibrium between the octahedral and square pyramidal form and the influence of an axial ligand on the molecular properties of V(IV)O complexes: a spectroscopic and DFT study | Chemistry (Weinheim an der Bergstrasse, Germany) |
